Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Semin Cancer Biol. 2021 Mar 27;78:17–22. doi: 10.1016/j.semcancer.2021.03.023

Table 1.

The role of chronic inflammation in tumor dormancy and relapse

Inflammation Cytokines Cells Outcome
Type I TNF-α, IFN-γ, IL-17, IL-6/sIL-6 Rα Th1, M1, ILC-1 Tumor dormancy
Type II IL-11, IL-22, IL-33, IL-6/mIL-6 Rα Th2, M2, ILC-2 Tumor relapse
Type I/II mIL-6 Rα > sIL-6 Rα Th17, ILC-3 Tumor relapse